^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy

Published date:
11/20/2020
Excerpt:
...Human leukemia CCRF-CEM SLFN11-proficient [parent]...cells were highly sensitive to carboplatin and nedaplatin compared to SLFN11-deficient cells...in vitro study, SLFN11-proficient cells were highly sensitive to platinum derivatives compared to SLFN11-deficient cells...Figure S1
DOI:
10.1186/s12885-020-07574-x